H
Hautarztpraxis Dr. med. Matthias Hoffmann | Witten, Germany
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Deucravacitinib
Ustekinumab
Upadacitinib
HRO350
Ruxolitinib
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
1 of 7 total trials
A study to evaluate the long-term safety of Deucravacitinib versus Ustekinumab in participants with psoriasis
Enrolling
Plaque Psoriasis
Drug: Ustekinumab
Drug: Deucravacitinib
Trial sponsors
A
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems